Focus: Cardinal Health is a $226.8B healthcare services and distribution company headquartered in Dublin, Ohio, serving pharmaceutical manufacturers, healthcare providers, and patients across the supply chain. As a publicly traded enterprise (NYSE: CAH) with 10,000+ employees, it operates at massive scale in pharmaceutical distribution, specialty care, and medical device logistics.
Profile data last refreshed 22h ago · AI intelligence enriched 2mo ago
Hot — 2051 jobs added in 30d
Net +1303 (2051 new, 748 removed). Aggressive expansion phase.
Best for supply chain, regulatory, quality, and commercial professionals seeking stable, growth-stage operations roles in a $226B public company; poor fit for research scientists and drug development specialists seeking pipeline exposure.
Help build intelligence for Cardinal Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Cardinal Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth - The Globe and Mail
CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth The Globe and Mail
Cardinal Health Q1 Earnings Call Highlights - Yahoo Finance
Cardinal Health Q1 Earnings Call Highlights Yahoo Finance
Cardinal Health Q1 Earnings Call Highlights - TradingView
Cardinal Health Q1 Earnings Call Highlights TradingView
Cardinal Health Raises Fiscal 2027 Growth Targets for Two Segments - www.tokenpost.com
Cardinal Health Raises Fiscal 2027 Growth Targets for Two Segments www.tokenpost.com
Cardinal Health Grows Drug Sales, Expands Home Care Business - Distribution Strategy Group
Cardinal Health Grows Drug Sales, Expands Home Care Business Distribution Strategy Group
CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth - The Globe and Mail
CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth The Globe and Mail
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Real-world use of tafasitamab for relapsed or refractory diffuse large B-cell lymphoma among racial and ethnic minorities in the United States.
Real-world treatment patterns and outcomes of patients treated with commercial chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo